Your browser doesn't support javascript.
loading
Evaluation of estimated glomerular function (eGFR) versus creatinine clearance (CrCl) to predict acute kidney injury when using zoledronate for the treatment of osteoporosis.
Schini, M; Peel, N; Toronjo-Urquiza, L; Thomas, E; Salam, S; Khwaja, A; Eastell, R; Walsh, J S.
Afiliação
  • Schini M; Academic Unit of Bone Metabolism, The University of Sheffield, Sheffield, UK. m.schini@sheffield.ac.uk.
  • Peel N; Metabolic Bone Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. m.schini@sheffield.ac.uk.
  • Toronjo-Urquiza L; Metabolic Bone Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Thomas E; Chemical Engineering Department, The University of Sheffield, Sheffield, UK.
  • Salam S; Pharmacy, Sheffield Teaching Hospitals, Sheffield, UK.
  • Khwaja A; Academic Unit of Bone Metabolism, The University of Sheffield, Sheffield, UK.
  • Eastell R; Sheffield Kidney Institute, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Walsh JS; Sheffield Kidney Institute, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Osteoporos Int ; 33(3): 737-744, 2022 Mar.
Article em En | MEDLINE | ID: mdl-34654939

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteoporose / Injúria Renal Aguda Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteoporose / Injúria Renal Aguda Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article